Literature DB >> 22012562

[Counselling centres for patients with cancer--analysis of service provision in Saxony].

S Singer1, N Bretschneider, A Lehmann-Laue, K Schröter, R Porzig, S Frenschkowski, S Riedel.   

Abstract

OBJECTIVES: The aim of this study was to understand the quantity and quality of psychosocial services offered at counselling centres for outpatients with cancer in Saxony, a federal state of Germany.
METHODS: Structured interviews with employees on site at the counselling centres in Saxony (N=30) and an analysis of their yearly reports were undertaken.
RESULTS: The majority of the counselling centres (N=25) was situated at local health departments. All institutions document their activities regularly and offer continuous training for their employees. Services include primarily information on and admission to social services whereas psychological and psychotherapeutic services are rare. Considering the guideline criteria for staffing with a ratio of one counsellor per 75,000 inhabitants, a total of 23 counsellors were lacking in the federal state of Saxony at the time of investigation.
CONCLUSIONS: The method of situating counselling centres at local health departments ensures good access for almost all cancer patients and relatives seeking counselling. However, due to restricted financial resources the services offered are not sufficient according to the guidelines and solutions for this situation are needed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22012562     DOI: 10.1055/s-0031-1285899

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  1 in total

1.  Experience of office-based haematologists and oncologists with outpatient psycho-social support services for cancer patients with and without migration background in Germany.

Authors:  Nicola Riccetti; Isabelle Hempler; Kerstin Hermes-Moll; Vitali Heidt; Thomas Walawgo; Susanne Singer
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.